Literature DB >> 25201387

Paediatric rheumatology: A disease activity index for juvenile SpA-a welcome addition.

Roberta A Berard1, Ronald M Laxer2.   

Abstract

A lack of universally accepted classification criteria for patients with juvenile spondyloarthritis (SpA) has hindered efforts to develop tools to assess the severity and progression of this disease. With the publication of a new juvenile SpA disease activity index, has this gap now been bridged, and is it a comprehensive tool for the clinic?

Entities:  

Mesh：

Year:  2014        PMID： 25201387     DOI： 10.1038/nrrheum.2014.150

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  8 in total

1.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

2.  Spondyloarthritis in a pediatric population: risk factors for sacroiliitis.

Authors:  Matthew L Stoll; Rafia Bhore; Molly Dempsey-Robertson; Marilynn Punaro
Journal:  J Rheumatol       Date:  2010-08-03       Impact factor: 4.666

3.  A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report.

Authors:  Giovanni Filocamo; Alessandro Consolaro; Benedetta Schiappapietra; Sara Dalprà; Bianca Lattanzi; Silvia Magni-Manzoni; Nicolino Ruperto; Angela Pistorio; Silvia Pederzoli; Adele Civino; Dinara Guseinova; Ester Masala; Stefania Viola; Alberto Martini; Angelo Ravelli
Journal:  J Rheumatol       Date:  2011-03-01       Impact factor: 4.666

4.  Development and retrospective validation of the juvenile spondyloarthritis disease activity index.

Authors:  Pamela F Weiss; Robert A Colbert; Rui Xiao; Chris Feudtner; Timothy Beukelman; Esi Morgan DeWitt; Ilaria Pagnini; Tracey B Wright; Carol A Wallace
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-12       Impact factor: 4.794

5.  American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Edward H Giannini; Bin Huang; Lukasz Itert; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-07       Impact factor: 4.794

Review 6.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

7.  Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors:  Pamela F Weiss; Timothy Beukelman; Laura E Schanberg; Yukiko Kimura; Robert A Colbert
Journal:  J Rheumatol       Date:  2012-10-15       Impact factor: 4.666

8.  Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Authors:  Gerd Horneff; Ruben Burgos-Vargas; Tamas Constantin; Ivan Foeldvari; Jelena Vojinovic; Vyacheslav G Chasnyk; Joke Dehoorne; Violeta Panaviene; Gordana Susic; Valda Stanevica; Katarzyna Kobusinska; Zbigniew Zuber; Richard Mouy; Ingrida Rumba-Rozenfelde; Luciana Breda; Pavla Dolezalova; Chantal Job-Deslandre; Nico Wulffraat; Daniel Alvarez; Chuanbo Zang; Joseph Wajdula; Deborah Woodworth; Bonnie Vlahos; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2013-05-21       Impact factor: 19.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.